World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
124
Citations
67380
World Ranking
3186
National Ranking
1760

Overview

Matthew R. Smith is affiliated with Harvard University in the United States. Their research primarily focuses on the medical field, with notable contributions to pulmonary and respiratory medicine, cancer research, radiology, nuclear medicine and imaging, surgery, and oncology.

The scientist has produced a significant body of work covering key topics such as:

  • Prostate Cancer Treatment and Research
  • Cancer, Lipids, and Metabolism
  • Radiopharmaceutical Chemistry and Applications
  • Prostate Cancer Diagnosis and Treatment
  • PARP inhibition in cancer therapy
  • Cancer Treatment and Pharmacology
  • Cancer Genomics and Diagnostics

Among the frequently published venues for Matthew R. Smith's research are:

  • Journal of Clinical Oncology
  • European Urology
  • European Journal of Cancer
  • Journal of Orthopaedics
  • The Journal of Urology

Regular co-authors include Karim Fizazi, Maha Hussain, Fred Saad, Neal D. Shore, and Bertrand Tombal, indicating a network of collaboration concentrated in oncology and related disciplines.

Key recent papers authored or co-authored by Matthew R. Smith include:

  • Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019 (2020) published in European Urology
  • Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021 (2022) published in European Urology
  • Accelerating precision medicine in metastatic prostate cancer (2020) published in Nature Cancer
  • Association of glucagon-like peptide receptor 1 agonist therapy with the presence of gastric contents in fasting patients undergoing endoscopy under anesthesia care: a historical cohort study (2024) published in Canadian Journal of Anesthesia/Journal canadien d anesthésie
  • Genetic stabilization of attenuated oral vaccines against poliovirus types 1 and 3 (2023) published in Nature

Their scientific output demonstrates a focus on oncology with an emphasis on prostate cancer, as well as research intersecting with pharmacology, diagnostics, and therapeutic methods within cancer treatment.

Best Publications

  • Isolation of rare circulating tumour cells in cancer patients by microchip technology.

    Sunitha Nagrath;Lecia V. Sequist;Shyamala Maheswaran;Daphne W. Bell;Daphne W. Bell

  • Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

    Charles J. Ryan;Matthew R. Smith;Johann S. De Bono;Arturo Molina

  • Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

    Karim Fizazi;Michael Carducci;Matthew Smith;Ronaldo Damião

  • Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy for Prostate Cancer

    Nancy L. Keating;A. James O'Malley;Matthew R. Smith

  • Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

    Howard I. Scher;Michael J. Morris;Walter M. Stadler;Celestia Higano

  • Denosumab in men receiving androgen-deprivation therapy for prostate cancer

    Matthew R. Smith;Blair Egerdie;Narciso Hernández Toriz;Robert Feldman

  • Prostate cancer. Clinical practice guidelines in oncology.

    James Mohler;Robert R. Bahnson;Barry Boston;J. Erik Busby

  • Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer

    Matthew R Smith;Fred Saad;Simon Chowdhury;Stéphane Oudard

  • Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group

    Glenn J. Bubley;Michael Carducci;William Dahut;Nancy Dawson

  • Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study

    Charles J. Ryan;Matthew R. Smith;Karim Fizazi;Fred Saad

  • Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer : results of a phase 3, randomised, placebo-controlled trial.

    Matthew R Smith;Fred Saad;Robert Coleman;Neal Shore

  • Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer.

    Matthew R. Smith;James Eastham;Donald M. Gleason;Daniel Shasha

  • Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer

    Karim Fizazi;Neal Shore;Teuvo L. Tammela;Albertas Ulys

  • Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer.

    Matthew R. Smith;Francis J. McGovern;Anthony L. Zietman;Mary Anne Fallon

  • Climate Change and Global Food Systems: Potential Impacts on Food Security and Undernutrition.

    Samuel Skipworth Myers;Matthew R. Smith;Sarah Guth;Christopher DeWeir Golden

  • Changes in body composition during androgen deprivation therapy for prostate cancer.

    Matthew R. Smith;Joel S. Finkelstein;Francis J. McGovern;Anthony L. Zietman

  • Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them

    Paul L. Nguyen;Shabbir M.H. Alibhai;Shehzad Basaria;Anthony V. D’Amico

  • Pathologic fractures correlate with reduced survival in patients with malignant bone disease.

    Fred Saad;Allan Lipton;Richard Cook;Yin Miao Chen

  • RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance

    David T. Miyamoto;Yu Zheng;Ben S. Wittner;Richard J. Lee

  • Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology.

    Glenn N. Levine;Anthony V. D'Amico;Peter Berger;Peter E. Clark

Frequent Co-Authors

Fred Saad
Fred Saad University of Montreal
Karim Fizazi
Karim Fizazi University of Paris-Saclay
Eric J. Small
Eric J. Small University of California, San Francisco
Neal D. Shore
Neal D. Shore Carolina Urologic Research Center
Philip W. Kantoff
Philip W. Kantoff Memorial Sloan Kettering Cancer Center
Johann S. de Bono
Johann S. de Bono Institute of Cancer Research
Howard I. Scher
Howard I. Scher Memorial Sloan Kettering Cancer Center
Nancy L. Keating
Nancy L. Keating Harvard University
Allan Lipton
Allan Lipton Penn State Milton S. Hershey Medical Center
Celestia S. Higano
Celestia S. Higano University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens doors to diverse paths beyond the MD degree. Today, flexible online education options make it easier to find a program that matches your goals and schedule.

For registered nurses looking to advance, dnp online programs offer a convenient way to pursue the highest clinical nursing degree. Those interested in beginning a nursing career quickly may consider a lpn program online, which can fast-track entry into practical nursing roles.

Mental health is a rapidly growing field, and accelerated msn psychiatric np programs prepare nurses for specialized careers in psychiatric and mental health care. Alternatively, students interested in the business side of healthcare can enroll in a healthcare administration degree online to pursue leadership positions in hospitals, clinics, and public health organizations.

Online degree options offer flexibility, affordability, and accelerated timelines—making a medical or healthcare career more accessible than ever.

Best Scientists Citing Matthew R. Smith

Trending Scientists

Recently Published Articles